RxNorm Names
LEADER LORATADINE
(loratadine)
tablet
[Cardinal Health]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e283afb8-9d26-4bd9-be77-e95e1d88aef8| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | Abbreviated New Drug Application |
USES
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- itchy, watery eyes
- sneezing
- itching of the nose or throat
WARNINGS
Ask a doctor before use if you have
liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product
do not take more than directed. Taking more than directed may cause drowsiness.
DIRECTIONS
adults and children 6 years and over: 1 tablet daily; not more than 1 tablet in 24 hours
OTHER INFORMATION
- TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
- store between 20 and 25° C (68 and 77° F)
- protect from excessive moisture
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
Compare to Claritin®active ingredient†
ORIGINAL PRESCRIPTION STRENGTH
Loratadine Tablets USP, 10 mg/Antihistamine
*When taken as directed. See Drug Facts Panel.
†Thisproduct is not manufactured or distributed by Schering-Plough HealthCare Products, Inc.,owner of theregisteredtrademarkClaritin®.
| LEADER LORATADINE
loratadine tablet |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Labeler - Cardinal Health (097537435) |
| Registrant - Ranbaxy Pharmaceuticals Inc. (937890044) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Ohm Laboratories Inc. | 051565745 | manufacture(37205-346) | |
Revised: 03/2012
Document Id: fe6bc6f0-dfff-49a9-8251-43dfa0a48df2
Set id: e283afb8-9d26-4bd9-be77-e95e1d88aef8
Version: 2
Effective Time: 20120319
Cardinal Health
Review RxNorm Normal Forms
